Delivery Order SPE2DB25D3504-SPE2DB25FVWFD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Opzelura 1.5% cream in a 60-gram unit, with a ceiling value of $1,310.45. This competitively awarded, firm fixed-price delivery order is set to be completed by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram quantity, valued at $5,766.81. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a Delivery Order (4568090195) to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,480.01 under firm fixed pricing terms, with performance to be completed by May 1, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 8, 2024, for the supply of Opzelura 1.5% cream in 60-gram units, valued at $22,363.62. This firm fixed price delivery order, with an ultimate completion date of November 12, 2024, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $17,181.12 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This contract, valued at $23,775.26, represents a firm fixed price delivery order with a completion date of June 2, 2025. The award was competitively procured without set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical procurement standards through open competition. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a ceiling value of $6,776.02 and an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a $6,139.48 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price, non-set-aside contract with a completion date of September 16, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $26,873.19 delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of May 16, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWFDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units, with a ceiling value of $7,528.48 and a firm fixed price structure. This delivery order is non-set-aside and represents a competitive award, with an ultimate completion date of September 5, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a leading pharmaceutical distributor and critical supplier to the federal healthcare system. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for the dermatological product Opzelura exemplifies the vendor's versatile role in fulfilling specialized pharmaceutical procurement requirements across multiple therapeutic domains within the federal supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 9/4/25 |